In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Amneal grosses $854mm in private placement

Executive Summary

Amneal Pharmaceuticals LLC (through Amneal Holdings) entered into definitive purchase agreements with institutional investors TPG and Fidelity Management & Research to gross $854mm through a private placement financing. The company plans to sell 46.8mm unregistered common shares at $18.25. The funding is concurrent with the merger the company has entered into with Impax Laboratories Inc.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • Drug Delivery
      • Macromolecule
      • Topical Delivery
      • Transdermal
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies